A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)

11/10/2017
14/03/2024
EU PAS number:
EUPAS21010
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

p11282 synopsis

English (96.74 KB - PDF) View document
Updated protocol

p11282-protocol-amendment4-synopsis

First published: 22/02/2024
English (102.35 KB - PDF) View document
Study results
Study report
Other information